The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance

In response to the opioid crisis, the Food and Drug Administration (FDA) has taken action on multiple fronts. We have approved better measures for treating opioid use disorder and preventing deaths from overdose, have launched efforts to inform more appropriate prescribing as a way to limit…

Read the full post on The New England Journal of Medicine: Search Results in Health Policy and Reform